Abstract (EN):
Summary: Patients infected with the human immunodeficiency virus (HIV) frequently present dysfunction related to hepatobiliary involvement. The more common clinic presentation are the alterations of the laboratorial tests, either reflecting hepatocellular damage (elevation of ALT and AST) or cholestasis (elevation of the alkaline fosfatase and gamma-GT). These can be due to primary or secondary infections of the liver and biliary system, to neoplastic involvement, or to alterations of the hepatic metabolism as a direct or indirect consequence of the HIV infection. AIDS cholangiopathy is a clinical-pathological entity characterized morphologically by alterations in the biliary system of individuals infected with HIV in severe immunosuppression (generally with CD4 lymphocytes countings inferior to 200/mm3), with serious deterioration of general state and with coexistent infection or neoplasia. It occurs approximately in 5% of AIDS patients. The patients usually present with pain in the right upper abdominal quadrant and accentuated elevation of the alkaline fosfatase and, sometimes, fever. Diagnosis should be suspected by the presence of biliary tree dilation in ultrassonography and is supported by characteristic aspects in endoscopic retrograde cholangiopancreatography (ERCP). We review some aspects of this entity regarding the pathogeny, clinical presentation, diagnosis, cholangiographic patterns and treatment.
Idioma:
Português
Tipo (Avaliação Docente):
Científica